C85.88 Other specified types of non-Hodgkin lymphoma, lymph nodes of multiple sites

Name of the Condition

• Other specified types of non-Hodgkin lymphoma, lymph nodes of multiple sites
• C85.88

Summary

Non-Hodgkin lymphoma (NHL) is a group of blood cancers affecting the lymphatic system. This code represents NHL types that do not fit into more specific subcategories and are explicitly documented as "other specified" in clinical records, with involvement of lymph nodes at multiple sites. The lymphatic system, part of the immune system, is involved in fighting infections, and NHL arises from abnormal lymphocyte growth.

Causes

The exact cause of non-Hodgkin lymphoma is often unknown but involves genetic mutations in lymphocytes. Factors such as viral infections (e.g., Epstein-Barr virus), immune system disorders, or exposure to certain chemicals may contribute to its development. These mutations disrupt normal cell regulation, leading to uncontrolled growth.

Risk Factors

• Advanced age (more common in older adults)
• Weakened immune system (e.g., HIV/AIDS, immunosuppressive therapy)
• Certain infections (e.g., hepatitis C, H. pylori)
• Exposure to chemicals (e.g., pesticides, herbicides)
• Family history of lymphoma
• Autoimmune conditions (e.g., rheumatoid arthritis)

Symptoms

• Swollen lymph nodes (neck, armpits, groin)
• Fever, night sweats, or unexplained weight loss
• Fatigue or weakness
• Abdominal pain or swelling
• Persistent cough or chest discomfort
• Itching or skin rashes

Diagnosis

Diagnosis typically involves a physical exam to check for swollen lymph nodes, blood tests to assess blood cell levels, imaging tests like CT or PET scans, and potentially a biopsy to examine lymphatic tissue. The specific sites of lymph node involvement are documented to confirm the diagnosis.

Treatment Options

Treatment depends on the specific type and progression of the lymphoma and may include chemotherapy, radiation therapy, immunotherapy, or targeted therapy. The choice of treatment is guided by the extent of disease and patient-specific factors.

Prognosis and Follow-Up

Prognosis varies based on the lymphoma type, stage, and patient health. Regular follow-up appointments are essential to monitor for recurrence or treatment-related complications. Long-term surveillance may be recommended to assess overall health and detect any new issues early.

Complications

Potential complications include infection due to weakened immunity, organ damage from tumor growth, or side effects from treatment such as fatigue, nausea, or increased risk of other cancers.

Lifestyle & Prevention

Maintaining a healthy lifestyle, including a balanced diet, regular exercise, and avoiding known risk factors like smoking or excessive alcohol, may support overall health. Preventing infections through vaccination and hygiene practices is also important for those with weakened immune systems.

When to Seek Professional Help

Seek medical attention if symptoms such as persistent swollen lymph nodes, unexplained weight loss, fever, or fatigue occur. Early evaluation is crucial for timely diagnosis and management.

Tips for Medical Coders

This code (C85.88) is used when the clinical documentation specifies non-Hodgkin lymphoma of other types with involvement of lymph nodes at multiple sites. Ensure the record clearly indicates both the "other specified" lymphoma type and the multiple-site lymph node involvement to support accurate coding. Documentation should align with the specific anatomical sites mentioned to avoid ambiguity.